共 160 条
[11]
Abelson JM(2007)Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet Lond Engl 370 319-328
[12]
Kessler RC(2010)Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia Psychiatry Res 181 51-56
[13]
Dervaux A(2015)Altered cortical maturation in adolescent cannabis users with and without schizophrenia Schizophr Res 162 143-152
[14]
Laqueille X(2009)Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use Schizophr Res 107 158-164
[15]
Bourdel MC(2014)Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Epilepsia 55 791-802
[16]
Bahorik AL(2016)Could cannabidiol be used as an alternative to antipsychotics? J Psychiatr Res 80 14-21
[17]
Newhill CE(2009)The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning Psychol Med 39 1607-1616
[18]
Queen CC(2004)The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 29 1558-1572
[19]
Eack SM(2012)The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample Schizophr Bull 38 316-330
[20]
Bersani G(2013)Cannabis use and cognitive functions in at-risk mental state and first episode psychosis Psychopharmacology (Berl) 230 299-308